Tinea Capitis (Scalp Ringworm)
The constellation of itchy scalp, annular scaly lesions with diffuse distribution, patchy hair loss, and tender occipital lymphadenopathy is most consistent with tinea capitis—a dermatophyte fungal infection of the scalp and hair follicles. This presentation represents an inflammatory variant of tinea capitis, which requires prompt recognition and systemic antifungal treatment to prevent permanent scarring alopecia 1.
Clinical Reasoning
The triad of scale, lymphadenopathy, and alopecia are cardinal clinical signs that strongly predict tinea capitis and justify starting treatment even before mycological confirmation 1. Your patient's presentation specifically suggests:
- Inflammatory tinea capitis: The diffuse pustular variant presents with patchy alopecia coexisting with scattered pustules or low-grade folliculitis, characteristically associated with painful regional lymphadenopathy 1
- Annular pattern: While annular lesions can occur in multiple conditions 2, when combined with scalp involvement, scaling, hair loss, and occipital adenopathy, this points definitively toward dermatophyte infection
Causative Organisms
The specific organism matters for treatment selection:
- Trichophyton species (T. tonsurans, T. violaceum, T. soudanense): Account for 50-90% of cases in the U.K., producing "black dot" alopecia with broken hair stubs and fine scale 1
- Microsporum species (M. canis, M. audouinii): Produce "grey patch" tinea with fine scaling and patchy circular alopecia; zoophilic species typically demonstrate more intense inflammatory response 1
Diagnostic Approach
Obtain scalp scrapings, hair plucks, or brush samples immediately for KOH microscopy and fungal culture 1. Look for:
- Scalpel scraping of scale and hair from affected areas
- Plucked hairs from the periphery of lesions
- Brush technique for improved sensitivity
However, do not delay treatment while awaiting culture results when the clinical presentation is this characteristic 1.
Treatment Algorithm
Immediate Management
Start oral antifungal therapy immediately based on local epidemiology 1:
For Trichophyton species (most likely in U.K./U.S.):
- Terbinafine (preferred for shorter duration):
- <20 kg: 62.5 mg daily for 2-4 weeks
- 20-40 kg: 125 mg daily for 2-4 weeks
40 kg: 250 mg daily for 2-4 weeks
For Microsporum species (if suspected or confirmed):
- Griseofulvin (only licensed option for children in U.K.):
- <50 kg: 15-20 mg/kg/day for 6-8 weeks
50 kg: 1 g/day for 6-8 weeks
- Take with fatty food to improve absorption
Adjunctive Measures
Add antifungal shampoo (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 1.
Critical Pitfalls to Avoid
- Do not use topical therapy alone—it will not achieve mycological cure 1
- Do not mistake this for bacterial abscess—kerion (severe inflammatory variant) is commonly misdiagnosed, leading to inappropriate antibiotic use 1
- Do not confuse treatment-related "id reaction" (pruritic papular eruption around ears) with drug allergy—this represents immune response to dying fungus and does not require stopping antifungals 1
- Terbinafine fails against Microsporum—it cannot reach scalp surface arthroconidia in prepubertal children due to lack of sebum/sweat excretion 1
Treatment Failure Protocol
If no clinical improvement after 4 weeks 1:
- First assess: compliance, drug absorption, reinfection
- If ongoing positive cultures with clinical improvement: continue current therapy 2-4 more weeks
- If no initial improvement: switch to second-line agent
- Itraconazole: 5 mg/kg/day for 2-4 weeks (effective against both Trichophyton and Microsporum)
- Or switch between terbinafine and griseofulvin based on culture results
Why This Matters for Outcomes
Untreated or inadequately treated tinea capitis can result in:
- Permanent scarring alopecia (especially with kerion or favus variants)
- Ongoing transmission to household contacts and classmates
- Progression to severe inflammatory kerion requiring prolonged treatment
The presence of tender lymphadenopathy indicates significant inflammatory response, making prompt systemic treatment essential to prevent permanent hair loss 1.